Pharmaceutical formulations for the treatment of inflammatory bowel disease

摘要

The invention relates to stable and ready-to-use enemas containing as active ingredient Beclomethasone dipropionate, for the treatment of inflammatory bowel disease. The formulations of the invention are characterized by homogeneity of the active ingredient at low concentration (0.05%) and fluidity of the suspension, which promote retrograde progression and homogeneous distribution of the active ingredient.